ACCESS PATHWAYEngraft prototype
Back to caseload

AP-009

Pediatric lymphoma, urban, commercial, under 25 miles

CAR-T · Phase 4, Collection & Preparation · 19 days in stage · 6 barriers, 3 blocking

On track

The engine, inverted

By factor

Each row is one fact about this patient and everything it sets in motion. 2 of 4 factors drive more than one barrier, which is where addressing the cause beats addressing the symptoms.

Dependents at home

drives 2 barriers

Young children / dependents at home needing care

  • Caregiver & psychosocial clearanceWatch

    Children or dependents at home make a month-long relocation and 24/7 caregiving hard to arrange

  • Housing insecurity / relocation burdenWatch

    Dependents at home make an extended relocation harder to sustain, both logistically and financially

Pediatric heme malignancy

drives 2 barriers

Diagnosis

  • Coverage lag after approvalWatch

    Newer pediatric indications are added to policies last, so coverage can lag behind the child's actual need

  • Pediatric / young-adult access gapModerate

    A pediatric blood cancer has a narrower set of approved options, concentrating care at a few specialized centers

2+ prior lines of therapy

drives 1 barrier

Line of therapy

  • Late referral / progression before treatmentWatch

    With 2+ lines already used, the window to refer while still eligible is closing

Pediatric (under 18)

drives 1 barrier

Age band

  • Pediatric / young-adult access gapModerate

    Few products are approved for children, so care often means a clinical trial at a distant pediatric center